Ginger caplets in Post operative nausea and vomiting

A Double Blind, placebo controlled, Clinical study to evaluate the efficacy and safety of Ginger caplets in Post operative nausea and vomiting

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2012/10/003063

Enrollment

Registered

2012-10-16

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Post operative nausea and vomiting

Interventions

Intervention1: GINGER CAPLET: Ginger caplets, 1 caplet twice daily for 10 days. Control Intervention1: Similar looking Placebo caplet: 1 caplet to be taken twice daily over the period of 10 days.

Eligibility

Inclusion criteria

Inclusion criteria: • Patients who are posted for abdominal surgery, hernia, orthopedic and gynecological surgeries and also those patients presenting with Post operative nausea & vomiting. • Patients willing to sign informed consent.

Exclusion criteria

Exclusion criteria: • Patients with severe vomiting related to CNS or severe gastrointestinal disorders. • Any evidence or history of hypersensitivity to herbal medicines. • Not willing to sign the informed consent or abide by the study procedure. • Pregnant or lactating women

Design outcomes

Primary

Measure	Time frame
symptomatic relief from clinical symptoms of post operative nausea and vomitingTimepoint: Assessment is done at entry day 3 day 6 and day 10	—

Secondary

Measure	Time frame
To assess the safety profile of Ginger caplets and overall complianceTimepoint: Assessment is done at entry day 3 day 6 and day 10	—

Countries

India

Contacts

Public ContactDr Prakash G Venkat

S.V.Pooja Hospital

gvprakash@rediffmail.com09949028879

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026